ASBP logo

ASBP
Aspire Biopharma Holdings Inc

2,281
Mkt Cap
$7.16M
Volume
160,878.00
52W High
$1,050.36
52W Low
$3.31
PE Ratio
-0.04
ASBP Fundamentals
Price
$5.49
Prev Close
$5.53
Open
$5.58
50D MA
$14.91
Beta
1.53
Avg. Volume
943,103.30
EPS (Annual)
-$491.27
P/B
0.24
$12.06
Loading...
Loading...
News
all
press releases
Healthcare Disruption, AI Biologics, and Wall Street Upgrades Ignite a Midday Market Surge
Healthcare innovators are pushing the markets today. $TGNT, $AGL, $ATRA, $ASBP
24-7 Market News
News Placeholder
More News
News Placeholder
ASBP Stock Jumps 21% On Buyback Offer – Retail Believes Every Dip’s A Buying Opportunity
Aspire Biopharma’s board approved a share repurchase program of up to $5 million, which will be funded from existing cash.
Stocktwits
News Placeholder
ASBP Bulls Back In Control After 78% Crash: What Changed?
The company closed a $21 million private placement that lifted its shareholders’ equity above Nasdaq’s minimum listing requirement.
Stocktwits
News Placeholder
LCID, ASBP, WLDS Stocks Hit 52-Week Lows: What Drove The Selloff?
The declines came amid leadership uncertainty, financing concerns, and downward revisions in price targets from Wall Street analysts.
Stocktwits
News Placeholder
LCID, ABT, ASBP Stocks Hit 52-Week Lows Today: What’s Driving The Selloff?
LCID and ABT each fell about 6% on Thursday, while ASBP plunged 45%, bucking a broader market rally.
Stocktwits
News Placeholder
ASBP Stock Soars 32% After Favorable Feedback From FDA For Its Aspirin –  Retail Expects Licensing Negotiations Soon
The FDA’s feedback supports a planned new drug application submission in the second half of 2026.
Stocktwits
<
...
1
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available